"Designing Growth Strategies is in our DNA"

Canada Sexually Transmitted Disease Testing Market Size, Share & Industry Analysis, By Product (Instruments and Reagents & Kits), By Setting (Laboratory Testing and Point-of-Care (POC)), By Application (Chlamydia, Syphilis, Genital Herpes, Gonorrhea, Human Immunodeficiency Virus, Human Papillomavirus (HPV), Trichomonas Vaginalis, Mycoplasma Genitalium, Candida Vaginitis, Bacterial Vaginosis, and Others), By End-user (Independent Clinical Laboratories, Hospital-based Laboratories, Homecare Settings, and Others), and Country Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI106798

 

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Incidence of Sexually Transmitted Diseases, Canada
    2. Key Industry Developments - Mergers, Acquisitions & Partnerships
    3. Overview of Canadian Guidelines on Sexually Transmitted Infections
    4. Technological Advancements: Sexually Transmitted Disease Testing
    5. Overview: At-Home Sampling/Testing Scenario
    6. New Product Launches
    7. Impact of COVID-19 on the Market
    8. Number of Tests, by Infection Types
    9. Distribution of Number of Tests, by Province/Territory
    10. Reimbursement Scenario: Sexually Transmitted Disease Testing, By Province
    11. Demographic Overview on Sexually Transmitted Disease Testing, By Province
  5. Canada Sexually Transmitted Disease Testing Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Product
      1. Instruments
      2. Reagents & Kits
    2. Market Analysis, Insights and Forecast – By Setting
      1. Laboratory Testing
      2. Point-of-Care (POC)
    3. Market Analysis, Insights and Forecast – By Application
      1. Chlamydia
      2. Syphilis
      3. Genital Herpes
      4. Gonorrhea
      5. Human Immunodeficiency Virus
      6. Human Papillomavirus (HPV)
      7. Trichomonas Vaginalis
      8. Mycoplasma Genitalium
      9. Candida Vaginitis
      10. Bacterial Vaginosis
      11. Others
    4. Market Analysis, Insights and Forecast – By End-user
      1. Independent Clinical Laboratories
      2. Hospital-based Laboratories
      3. Homecare Settings
      4. Others
  6. Competitive Analysis
    1. Canada Market Share Analysis (2023)
    2. Company Profiles
      1. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Abbott
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. BD (Becton, Dickinson and Company)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Hologic, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. Cepheid (Danaher Corporation)
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Thermo Fisher Scientific Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. bioMerieux, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Bio-Rad Laboratories, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. DiaSorin S.p.A.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. Seegene Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Table 01: Canada Sexually Transmitted Disease Testing Market Revenue (USD million) Forecast, By Product, 2019–2032

Table 02: Canada Sexually Transmitted Disease Testing Market Revenue (USD million) Forecast, By Setting, 2019-2032

Table 03: Canada Sexually Transmitted Disease Testing Market Revenue (USD million) Forecast, By Application, 2019-2032

Table 04: Canada Sexually Transmitted Disease Testing Market Revenue (USD million) Forecast, By End-user, 2019-2032

Figure 01: Canada Sexually Transmitted Disease Testing Market Revenue Breakdown (USD million, %) By Product, 2023 & 2032

Figure 02: Canada Sexually Transmitted Disease Testing Market Value Share (%), By Product, 2023 & 2032

Figure 03: Canada Sexually Transmitted Disease Testing Market Value Share (%), By Setting, 2023 & 2032

Figure 04: Canada Sexually Transmitted Disease Testing Market Value Share (%), By application, 2023 & 2032

Figure 05: Canada Sexually Transmitted Disease Testing Market Value Share (%), By End-user, 2023 & 2032

Figure 06: Canada Sexually Transmitted Disease Testing Market Share (%), By Company, 2023

Canada Sexually Transmitted Disease Testing Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 134
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase